Sana Biotechnology is based in Seattle, WA. It has raised $700M in total funding. Latest round: IPO.
Sana Biotechnology is based in Seattle, WA. Sana Biotechnology has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in June 2020. The round record for Sana Biotechnology runs through 2020; nothing later has been disclosed. Investors on record include Flagship Pioneering, ARCH Venture Partners, F-Prime Capital, Canada Pension Plan Investment Board, Baillie Gifford, Alaska Permanent Fund and 5 others. 11 distinct backers are named across the disclosed rounds.
Totals shown for Sana Biotechnology aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026